From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research

被引：0

作者：

Cynthia L. Hsu

Rohit Loomba

机构：

[1] University of California at San Diego,Division of Gastroenterology and Hepatology, Department of Medicine

[2] VA San Diego Healthcare System,Department of Medicine

[3] University of California at San Diego,MASLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine

[4] University of California at San Diego,The Herbert Wertheim School of Public Health and Human Longevity Science

来源：

Nature Metabolism | 2024年 / 6卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Non-alcoholic liver disease (NAFLD) is now metabolic dysfunction-associated steatotic liver disease (MASLD), emphasizing the key metabolic factors of obesity, insulin resistance, vascular dysfunction and dyslipidaemia. Here, we discuss impacts on the existing body of clinical and preclinical liver disease research and on research moving forward.

引用

页码：600 / 602

页数：2

共 50 条

[41] Deciphering the implications of MAFLD and MASLD definitions in the NAFLD population: results from a single-center biopsy study [J].

Kaya Eda1 ;

不详 ;

Yilmaz Yusuf6 ;

不详 ;

不详 .

中华医学杂志英文版, 2024, 137 (05)

[42] Deciphering the implications of MAFLD and MASLD definitions in the NAFLD population: results from a single-center biopsy study [J].

Kaya, Eda ;

Yilmaz, Yusuf .

CHINESE MEDICAL JOURNAL, 2024, 137 (05) :616-618

[43] IMPACT OF NEW NOMENCLATURE ON HOSPITALIZATION OUTCOMES: COMPARING MASLD, METALD, AND ALD [J].

Franco, Gian Rodriguez ;

Sollenberger, Christopher ;

Massie, Tammy ;

Hsu, Christine .

HEPATOLOGY, 2024, 80 :S833-S834

[44] NAFLD: genetics and its clinical implications [J].

Sharma, Dixa ;

Mandal, Palash .

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (09)

[45] Mechanisms of Lipotoxicity in NAFLD and Clinical Implications [J].

Ibrahim, Samar H. ;

Kohli, Rohit ;

Gores, Gregory J. .

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2011, 53 (02) :131-140

[46] From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction [J].

Ciardullo, Stefano ;

Perseghin, Gianluca .

METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (04)

[47] From NAFLD to MASLD: transforming steatotic liver disease diagnosis and management [J].

Iruzubieta, Paula ;

Jimenez-Gonzalez, Carolina ;

Crespo, Javier ;

Cabezas, Joaquin .

METABOLISM AND TARGET ORGAN DAMAGE, 2025, 5 (01)

[48] Can we use old NAFLD data under the new MASLD definition? [J].

Song, Sherlot Juan ;

Lai, Jimmy Che-To ;

Lai-Hung, Jimmy Grace ;

Wai-Sun, Vincent ;

Yip, Terry Cheuk-Fung .

JOURNAL OF HEPATOLOGY, 2024, 80 (02) :e54-e56

[49] New insights into NAFLD based on preclinical MRI studies [J].

Bamburowicz-Klimkowska, Magdalena ;

Ruzycka-Ayoush, Monika ;

Cieszanowski, Andrzej ;

Szeszkowski, Wojciech ;

Bialek, Malgorzata ;

Malkowska, Anna ;

Grudzinski, Ireneusz P. .

CHEMISTRY AND PHYSICS OF LIPIDS, 2022, 244

[50] Preclinical Sex Differences in Depression and Antidepressant Response: Implications for Clinical Research [J].

Kokras, Nikolaos ;

Dalla, Christina .

JOURNAL OF NEUROSCIENCE RESEARCH, 2017, 95 (1-2) :731-736

← 1 2 3 4 5 →